These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 18997034

  • 1. Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy.
    Lee PH, Yong SW, An YS.
    J Nucl Med; 2008 Dec; 49(12):2006-11. PubMed ID: 18997034
    [Abstract] [Full Text] [Related]

  • 2. [Cerebral glucose metabolism in Parkinson's disease with dementia].
    Ma AJ, Zhang BS, Pan XD, Gao S, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Oct 14; 88(37):2623-8. PubMed ID: 19080710
    [Abstract] [Full Text] [Related]

  • 3. Changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy: a preliminary study.
    Kim YW, Shin JC, An YS.
    Ann Nucl Med; 2010 Jun 14; 24(5):363-9. PubMed ID: 20237871
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E, Na DL, Kim SE.
    J Nucl Med; 2005 Feb 14; 46(2):233-9. PubMed ID: 15695781
    [Abstract] [Full Text] [Related]

  • 5. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.
    Kim IJ, Kim SJ, Kim YK.
    Acta Radiol; 2009 Dec 14; 50(10):1169-74. PubMed ID: 19922315
    [Abstract] [Full Text] [Related]

  • 6. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
    Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE.
    J Nucl Med; 2011 Jun 14; 52(6):848-55. PubMed ID: 21571793
    [Abstract] [Full Text] [Related]

  • 7. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May 14; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

  • 8. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E.
    J Nucl Med; 1998 Nov 14; 39(11):1875-8. PubMed ID: 9829574
    [Abstract] [Full Text] [Related]

  • 9. Cholinergic deficit and response to donepezil therapy in Parkinson's disease with dementia.
    Hiraoka K, Okamura N, Funaki Y, Hayashi A, Tashiro M, Hisanaga K, Fujii T, Takeda A, Yanai K, Iwata R, Mori E.
    Eur Neurol; 2012 Nov 14; 68(3):137-43. PubMed ID: 22832236
    [Abstract] [Full Text] [Related]

  • 10. The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia.
    Werber EA, Rabey JM.
    J Neural Transm (Vienna); 2001 Nov 14; 108(11):1319-25. PubMed ID: 11768630
    [Abstract] [Full Text] [Related]

  • 11. Parkinson's disease dementia: clinical correlates of brain spect perfusion and treatment.
    Kramberger MG, Stukovnik V, Cus A, Repovs G, Tomse P, Meglic NP, Garasević Z, Jensterle J, Pirtosek Z.
    Psychiatr Danub; 2010 Sep 14; 22(3):446-9. PubMed ID: 20856190
    [Abstract] [Full Text] [Related]

  • 12. Cholinergic and perfusion brain networks in Parkinson disease dementia.
    Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O'Brien JT, Taylor JP.
    Neurology; 2016 Jul 12; 87(2):178-85. PubMed ID: 27306636
    [Abstract] [Full Text] [Related]

  • 13. Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve.
    Perneczky R, Diehl-Schmid J, Förstl H, Drzezga A, Kurz A.
    Int J Geriatr Psychiatry; 2007 Nov 12; 22(11):1135-40. PubMed ID: 17479980
    [Abstract] [Full Text] [Related]

  • 14. [A study on the cerebral glucose metabolism in progressive supranuclear palsy].
    Ma AJ, Guo XJ, Li DC, Zhang BS, Pan XD.
    Zhonghua Nei Ke Za Zhi; 2012 Nov 12; 51(11):885-8. PubMed ID: 23291028
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA, Ott BR, Lapane KL, Reinert SE, Machan JT, Dore DD.
    Am J Geriatr Pharmacother; 2009 Apr 12; 7(2):74-83. PubMed ID: 19447360
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.